4.3 Article

Construction of a pathological risk model of occult lymph node metastases for prognostication by semi-automated image analysis of tumor budding in early-stage oral squamous cell carcinoma

Journal

ONCOTARGET
Volume 8, Issue 11, Pages 18227-18237

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.15314

Keywords

oral squamous cell carcinoma; digital pathology; tumor budding; REMARK guidelines

Funding

  1. Danish Council for Independent Research [DFF-4004-00193B]
  2. non-profit Candy Foundation

Ask authors/readers for more resources

It is challenging to identify at diagnosis those patients with early oral squamous cell carcinoma (OSCC), who have a poor prognosis and those that have a high risk of harboring occult lymph node metastases. The aim of this study was to develop a standardized and objective digital scoring method to evaluate the predictive value of tumor budding. We developed a semi-automated image-analysis algorithm, Digital Tumor Bud Count (DTBC), to evaluate tumor budding. The algorithm was tested in 222 consecutive patients with early-stage OSCC and major endpoints were overall (OS) and progression free survival (PFS). We subsequently constructed and cross-validated a binary logistic regression model and evaluated its clinical utility by decision curve analysis. A high DTBC was an independent predictor of both poor OS and PFS in a multivariate Cox regression model. The logistic regression model was able to identify patients with occult lymph node metastases with an area under the curve (AUC) of 0.83 (95% CI: 0.78-0.89, P < 0.001) and a 10-fold cross-validated AUC of 0.79. Compared to other known histopathological risk factors, the DTBC had a higher diagnostic accuracy. The proposed, novel risk model could be used as a guide to identify patients who would benefit from an up-front neck dissection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Ophthalmology

Prevalence and prognostic value of MYD88 and CD79B mutations in ocular adnexal large B-cell lymphoma: a reclassification of ocular adnexal large B-cell lymphoma

Marina Knudsen Kirkegaard, Marthe Minderman, Lene Dissing Sjo, Steven T. Pals, Patrick R. G. Eriksen, Steffen Heegaard

Summary: This study aimed to reclassify ocular adnexal large B-cell lymphomas (OA-LBCLs) and investigate the prevalence and association of MYD88 and CD79B mutations with clinical parameters. The results revealed that OA-LBCL mainly consists of two subtypes, and MYD88 mutations, as well as cMYC/BCL2 double-expressor DLBCL, are associated with poor prognosis.

BRITISH JOURNAL OF OPHTHALMOLOGY (2023)

Article Oncology

Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial

Luc-Matthieu Fornecker, Julien Lazarovici, Igor Aurer, Rene-Olivier Casasnovas, Anne-Claire Gac, Christophe Bonnet, Krimo Bouabdallah, Pierre Feugier, Lena Specht, Lysiane Molina, Mohamed Touati, Cecile Borel, Aspasia Stamatoullas, Emmanuelle Nicolas-Virelizier, Laurent Pascal, Pieternella Lugtenburg, Nicola Di Renzo, Thierry Vander Borght, Alexandra Traverse-Glehen, Peggy Dartigues, Martin Hutchings, Annibale Versari, Michel Meignan, Massimo Federico, Marc Andre

Summary: This study evaluated the efficacy and safety of brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine (BV-AVD) in early-stage unfavorable Hodgkin lymphoma. The results showed that BV-AVD had a higher PET-negative rate compared to ABVD after two cycles. High total metabolic tumor volume was associated with shorter progression-free survival.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Review Allergy

An update on patient reported outcomes in type 2 inflammation airway disease

Christian Korsgaard Pedersen, Christiane Haase, Kasper Aanaes, Christian von Buchwald, Vibeke Backer

Summary: Patient reported outcome measures (PROMs) are important in assessing global airway disease caused by type-2 inflammation, as they provide insights into patients' perspective on symptoms, treatment, disease control, and possible comorbidity. This review investigates newly developed PROMs for global airway disease and provides an overview of commonly used PROMs in managing the condition.

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Editorial Material Veterinary Sciences

Introducing canine lifestyle medicine and access to care in context of an interprofessional framework

Annika Linde, John Tegzes, Tonatiuh Melgarejo, Dominique Griffon, Vet Med

AMERICAN JOURNAL OF VETERINARY RESEARCH (2023)

Article Oncology

Tumor volume definitions in head and neck squamous cell carcinoma - Comparing PET/MRI and histopathology

Emmanouil Terzidis, Jeppe Friborg, Ivan R. Vogelius, Giedrius Lelkaitis, Christian von Buchwald, Anders B. Olin, Helle H. Johannesen, Barbara M. Fischer, Irene Wessel, Jacob H. Rasmussen

Summary: This study aimed to evaluate the mismatch between tumor volumes defined from PET/MRI hybrid imaging and pathology, and its potential clinical impact. The results showed a mismatch between imaging and pathological defined tumor volumes in all patients. However, after the addition of a clinical 5 mm margin, the entire pathological volume was fully encompassed in the imaging-defined tumor volume in most patients.

RADIOTHERAPY AND ONCOLOGY (2023)

Article Respiratory System

Higher SARS-CoV-2 detection of oropharyngeal compared with nasopharyngeal or saliva specimen for molecular testing: a multicentre randomised comparative accuracy study

Tobias Todsen, Martin G. Tolsgaard, Thomas Benfield, Fredrik Folke, Kathrine K. Jakobsen, Niels Tobias Gredal, Annette K. Ersboll, Christian von Buchwald, Nikolai Kirkby

Summary: This study compared the detection rate of SARS-CoV-2 using nasopharyngeal swab (NPS), oropharyngeal swab (OPS), and saliva specimen collection. The results showed that OPS had the highest detection rate, while saliva sampling had the lowest. OPS sampling had higher detection rate and lower discomfort compared to NPS. Although saliva sampling had the lowest detection rate, it was the least costly.

THORAX (2023)

Editorial Material Virology

Special Issue HPV in the Head and Neck Region 2.0

Tina Dalianis, Christian von Buchwald, Anders Nasman, Stina Syrjanen

VIRUSES-BASEL (2023)

Review Oncology

A systematic review on clinical adaptive radiotherapy for head and neck cancer

Anne Marie Lindegaard, Katrin Hakansson, Mogens Bernsdorf, Anita B. Gothelf, Claus A. Kristensen, Lena Specht, Ivan R. Vogelius, Jeppe Friborg

Summary: This systematic review examines the clinical and dosimetric benefits of adaptive radiotherapy (ART) in head and neck cancer patients. The results show that ART can effectively reduce doses to organs at risk, but the impact on toxicity and disease control is uncertain. Larger, prospective trials with well-defined control groups are needed to further investigate these findings.

ACTA ONCOLOGICA (2023)

Letter Oncology

The potential for local ablative therapy of oligometastases in head and neck squamous cell carcinoma: a real-world data analysis

Julie Kjems, Michael R. T. Laursen, Claus A. Kristensen, Anita B. Gothelf, Mogens Bernsdorf, Lena Specht, Anne K. Berthelsen, Ivan R. Vogelius, Gitte F. Persson, Jeppe Friborg

ACTA ONCOLOGICA (2023)

Editorial Material Otorhinolaryngology

Validity of the large language model ChatGPT (GPT4) as a patient information source in otolaryngology by a variety of doctors in a tertiary otorhinolaryngology department

Jacob P. S. Nielsen, Christian von Buchwald, Christian Gronhoj

ACTA OTO-LARYNGOLOGICA (2023)

Review Otorhinolaryngology

A systematic review on the role of biomarkers in liquid biopsies and saliva samples in the monitoring of salivary gland cancer

Theresa Emilia Britze, Kathrine Kronberg Jakobsen, Christian Gronhoj, Christian von Buchwald

Summary: This study reviewed the role of biomarkers in liquid biopsies and saliva samples in monitoring salivary gland cancer. Five studies identified potential biomarkers in blood and saliva samples, and concluded that further research is needed before the method can be used for diagnosis.

ACTA OTO-LARYNGOLOGICA (2023)

Review Oncology

Personalised therapy in follicular lymphoma - is the dial turning?

Kim M. Linton, Lena Specht, Astrid Pavlovsky, Carrie A. Thompson, Eva Kimby, Daphne de Jong, Loretta J. Nastoupil, Anne-Segolene Cottereau, Carla Casulo, Clementine Sarkozy, Jessica Okosun

Summary: Follicular lymphoma, the most common indolent lymphoma in western countries, has a favorable prognosis but includes high-risk groups with poor outcomes. This review discusses recent updates in risk stratification and treatment approaches, including upfront treatment for limited and advanced stage follicular lymphoma, as well as options for relapsed, refractory disease. It also highlights the need for precise and prospective selection of optimal treatment based on varying risks, which may be achieved through a better understanding of the biology of different phenotypes and improved imaging and biomarker-based tools.

HEMATOLOGICAL ONCOLOGY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Urokinase-Type Plasminogen Activator Receptor (uPAR) Expression and [64Cu]Cu-DOTA-AE105 uPAR-PET/CT in Patient-Derived Xenograft Models of Oral Squamous Cell Carcinoma

Mads Lawaetz, Tina Binderup, Anders Christensen, Karina Juhl, Giedrius Lelkaitis, Eva Lykke, Line Knudsen, Christian von Buchwald, Andreas Kjaer

Summary: This study established oral squamous cell carcinoma (OSCC) PDX models and evaluated the effectiveness of [Cu-64]Cu-uPAR-PET/CT for tumor imaging in these models.

MOLECULAR IMAGING AND BIOLOGY (2023)

Editorial Material Oncology

EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report

Mario A. Hermsen, Matt Lechner, Leticia Oliveira Ferrer, Annalisa Trama, Patrick Rene Gerhard Eriksen, Eva Martinez-Balibrea, Christian von Buchwald

Summary: Sinonasal cancer is a rare and heterogeneous group of tumors with poor outcomes. Due to their low incidence, collaboration between physicians and researchers is essential for advancement in clinical management and translational research. This report discusses a conference organized by EUSICA and COST Action 'IMMUNO-model' that focused on collaboration, preclinical tumor and immuno models, treatment options, genetic characterization, and cancer registry for sinonasal cancer.

ORAL ONCOLOGY (2023)

Article Medicine, Research & Experimental

Effectiveness and safety of mesenchymal stem/stromal cell for radiation-induced hyposalivation and xerostomia in previous head and neck cancer patients (MESRIX-III): a study protocol for a single-centre, double-blinded, randomised, placebo-controlled, phase II study

Kathrine Kronberg Jakobsen, Amanda-Louise Fenger Carlander, Christian Gronhoj, Tobias Todsen, Jacob Melchiors, Natasja Paaske, Anne Kathrine ostergaard Madsen, Jens Kastrup, Annette Ekblond, Mandana Haack-Sorensen, Mohammad Farhadi, Christian Maare, Jeppe Friborg, Charlotte Duch Lynggard, Christian von Buchwald

Summary: This is a trial investigating the safety and effectiveness of allogeneic stem cell injection for treating radiation-induced hyposalivation and xerostomia in head and neck cancer patients. The study aims to evaluate changes in saliva flow rate, quality of life, and safety of the treatment.

TRIALS (2023)

No Data Available